|
|
|
[ Latest Press Releases ] [ From The Press ]
|
Connexios Outsources Literature Curation to Molecular Connections
Bangalore, India - Molecular Connections today announced that it would be carrying out scientific literature mining for Connexios to assist the latter in its high throughput experiment validation and target discovery purposes.
As a part of the agreement, the existing literature mining team at Connexios would be taken over by Molecular Connections. Molecular Connections, would use its proprietary workflows and technologies and its long standing experience in manual curation of biomedical literature to create customized pathway information for Connexios.
This would also allow Connexios to focus on its vision of being a discovery led life-sciences company. Connexios also possesses a state of the art wet lab with cell-based assay design and high throughput target identification facility, and a knowledge-driven systems biology platform which would not be a part of the deal.
Jignesh Bhate, CEO of Molecular Connections¿ said, "Molecular Connections has come out as a clear leader in the field of high quality curation for protein interactions and pathway biology. The collaborations with Connexios is sure to open new frontiers in establishing technology partnerships across both the companies."
Dr Venkatachalam Suri, CEO of Connexios commenting on the deal mentioned "We evaluated many literature curation vendors and found Molecular Connections a quality conscious company with a strong technology platform, a proven track record and high ethics". It is a win-win situation for both companies.
About Molecular Connections
Molecular Connections provides high quality, cost effective bioinformatic services in the areas of genomics, proteomics, ADME Tox, clinical diseases, drugs, chemistry, patents. Dr. Limsoon Wong is the Chairman of Molecular Connections. Customers of Molecular Connections include leading pharmaceutical and biotechnology discovery companies, genomics and proteomics companies, medical technology and equipment companies and academic institutions spanning across the globe.
About Connexios Life Sciences
Connexios Life Sciences is a systems biology based drug discovery company founded by an interdisciplinary group of scientists in Bangalore, India. The drug discovery platform of Connexios comprises of a set of in-vitro and in-silico pharmacological screens derived through a systems biology approach. Such a cell based systems pharmacology approach enables Connexios to comprehensively characterize drug candidates for their efficacy, ADME and Tox, at an early stage. This approach serves to reduce cycle time and costs and increase the efficiency of downstream animal-based studies leading upto clinical development. Connexios is developing an internal pipeline of molecules using this discovery platform
More information >>
|
|
